Pamorelin LA 11.25 mg
Pamorelin LA 11.25 mg is a medicine authorised by Swissmedic under authorisation number 56349. The authorisation holder is Debiopharm Research & Manufacturing SA. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 09 February 2005 and the authorisation is valid without a time limit. ATC code L02AE04 places the medicine in the group Endocrine therapy.
| Authorisation number | 56349 |
|---|---|
| Name | Pamorelin LA 11.25 mg |
| Full name | Pamorelin LA 11.25 mg, poudre et solvant pour suspension injectable à libération prolongée |
| Authorisation holder | Debiopharm Research & Manufacturing SA |
| Medicinal product code | Synthetic medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | L02AE04 |
| First authorisation | 09 February 2005 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Pamorelin LA 11.25 mg, poudre et solvant pour suspension injectable à libération prolongée | A | 09 February 2005 |
| 3 | Pamorelin LA 11.25 mg, poudre et solvant pour suspension injectable à libération prolongée | A | 07 September 2018 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 2 | 1 | Set | L02AE04 | 07.16.2. | A |
| 1 | 1 | Set | L02AE04 | 07.16.2. | A |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Pamorelin LA 11.25 mg authorised in Switzerland?
Yes. Pamorelin LA 11.25 mg is authorised by Swissmedic under authorisation number 56349, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Pamorelin LA 11.25 mg have?
Pamorelin LA 11.25 mg is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Pamorelin LA 11.25 mg?
The authorisation holder is Debiopharm Research & Manufacturing SA. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.